TY - JOUR T1 - A Time-Dependent SEIRD Model for Forecasting the COVID-19 Transmission Dynamics JF - medRxiv DO - 10.1101/2020.05.29.20113571 SP - 2020.05.29.20113571 AU - Taarak Rapolu AU - Brahmani Nutakki AU - T. Sobha Rani AU - S. Durga Bhavani Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/13/2020.05.29.20113571.abstract N2 - The spread of a disease caused by a virus can happen through human to human contact or could be from the environment. A mathematical model could be used to capture the dynamics of the disease spread to estimate the infections, recoveries, and fatalities that may result from the disease. An estimation is crucial to make policy decisions and for the alerts for the medical emergencies that may arise. Many epidemiological models are being used to make such an estimation. One major factor that is important in the forecasts using the models is the dynamic nature of the disease spread. Unless we can come up with a way of estimating the parameters that guide this dynamic spread, the models may not give accurate forecasts. The main principle is to keep the model generic while making minimal assumptions. In this work, we have derived a data-driven model from SEIRD, where we attempt to forecast Infected, Recovered and Deceased rates of COVID-19 up to a week. A method of estimating the parameters of the model is also discussed thoroughly in this work. The model is tested for India at a district level along with the most affected foreign cities like Lombardia from Italy and Moscow from Russia.The forecasts can help the governments in planning for emergencies such as ICU requirements, PPEs, hospitalizations, and so on as the infection is going to be prevalent for some time until a vaccine or cure is invented.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We declare that no animals and humans are involved and that this is purely computational work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in this manuscript is open-sourced and is available in the below-mentioned links. https://api.covid19india.org/ https://www.worldometers.info/coronavirus/ https://github.com/pcm-dpc/COVID-19/blob/master/dati-regioni/dpc-covid19-ita-regioni.csv https://www.kaggle.com/kapral42/covid19-russia-regions-cases?select=covid19-russia-cases-scrf.csv ER -